A detailed history of Cordasco Financial Network transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cordasco Financial Network holds 1,315 shares of BMY stock, worth $74,705. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,315
Previous 1,307 0.61%
Holding current value
$74,705
Previous $95,000 6.32%
% of portfolio
0.07%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

BUY
$72.62 - $79.98 $580 - $639
8 Added 0.61%
1,315 $101,000
Q1 2022

Apr 21, 2022

BUY
$61.48 - $73.72 $614 - $737
10 Added 0.77%
1,307 $95,000
Q4 2021

Jan 24, 2022

BUY
$53.63 - $62.52 $482 - $562
9 Added 0.7%
1,297 $81,000
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $12,189 - $14,277
-206 Reduced 13.79%
1,288 $76,000
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $557 - $606
9 Added 0.61%
1,494 $100,000
Q1 2021

Apr 12, 2021

SELL
$59.34 - $66.74 $2,492 - $2,803
-42 Reduced 2.75%
1,485 $94,000
Q4 2020

Jan 26, 2021

BUY
$57.74 - $65.43 $12,009 - $13,609
208 Added 15.77%
1,527 $95,000
Q3 2020

Oct 13, 2020

SELL
$57.43 - $63.64 $11,083 - $12,282
-193 Reduced 12.76%
1,319 $80,000
Q2 2020

Jul 13, 2020

BUY
$54.82 - $64.09 $10,141 - $11,856
185 Added 13.94%
1,512 $89,000
Q1 2020

Apr 24, 2020

BUY
$46.4 - $67.43 $6,124 - $8,900
132 Added 11.05%
1,327 $74,000
Q4 2019

Jan 22, 2020

BUY
$49.21 - $64.19 $344 - $449
7 Added 0.59%
1,195 $77,000
Q3 2019

Oct 17, 2019

BUY
$42.77 - $50.71 $427 - $507
10 Added 0.85%
1,188 $60,000
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $401 - $444
9 Added 0.77%
1,178 $53,000
Q1 2019

Apr 10, 2019

BUY
$45.12 - $53.8 $46,428 - $55,360
1,029 Added 735.0%
1,169 $56,000
Q3 2018

Oct 10, 2018

SELL
$55.19 - $62.25 $11,203 - $12,636
-203 Reduced 59.18%
140 $9,000
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $18,943 - $21,862
343
343 $22,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.